Cellebrite DI (CLBT) Cash Flow: Operating & Free Cash Flow

Cellebrite DI Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Cellebrite DI Ltd. (CLBT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Operating Activities
Net Income	78.33	-283.01	-81.10	120.81	71.40	5.78	-1.88
Depreciation & Amortization	11.87	10.61	10.01	9.19	7.01	5.88	4.08
Deferred Income Tax	0.08	-4.02	5.13	-2.39	-1.64	-2.82	-1.67
Stock Based Compensation	44.89	30.58	19.00	13.71	6.48	7.27	12.76
Change in Working Capital	46.61	42.05	38.52	-2.82	20.68	49.71	2.71
Change in Accounts Receivable	-15.78	-5.83	2.27	-12.89	-1.96	-19.73	-12.22
Change in Inventory	1.63	0.98	0.24	-3.68	-1.80	-0.69	0.79
Change in Accounts Payable	9.19	2.76	3.69	-5.47	4.24	-1.43	0.97
Change in Other Working Capital	-8.16	4.24	32.31	19.22	20.20	71.57	13.16
Other Operating Activities	-8.16	331.95	110.51	-117.92	-67.87	0.69	0.13
Net Cash from Operating Activities	173.54	132.17	102.06	20.58	36.05	66.51	16.13
Investing Activities
Capital Expenditures	-13.23	-8.57	-7.92	-9.09	-8.11	-6.18	-6.21
Acquisitions	-147.46	-2.75	0.00	0.00	-20.00	-15.05	0.00
Purchases of Investments	-508.23	-127.79	-144.32	-165.36	-21.00	-138.50	0.00
Sales/Maturities of Investments	400.66	59.97	129.70	83.22	94.34	153.28	0.00
Other Investing Activities	0.86	-68.30	-2.69	-2.19	-3.00	0.00	-40.51
Net Cash from Investing Activities	-268.25	-149.47	-22.54	-91.23	45.23	-6.45	-46.72
Financing Activities
Debt Repayment	4.59	0.00	0.00	0.00	0.00	0.00	0.00
Common Stock Issued	25.05	20.66	0.00	0.00	0.00	0.00	0.00
Common Stock Repurchased	0.00	0.00	0.00	0.00	0.00	-0.09	-0.81
Dividends Paid	0.00	0.00	0.00	0.00	-100.00	-10.00	-25.00
Other Financing Activities	0.00	-0.01	21.77	13.97	31.60	1.49	101.35
Net Cash from Financing Activities	25.05	20.65	21.77	13.97	-68.40	-8.59	75.54
Summary
Effect of Forex Changes on Cash	2.45	-1.21	0.59	-1.64	-0.75	0.70	-0.07
Net Change in Cash	-69.65	2.14	101.87	-58.33	12.13	52.16	44.88
Cash at Beginning of Period	191.66	189.52	87.65	145.97	133.85	81.68	36.80
Cash at End of Period	124.46	191.66	189.52	87.65	145.97	133.85	81.68
Free Cash Flow	160.32	123.61	94.14	11.49	27.94	60.33	9.92
Supplemental Disclosures
Income Taxes Paid	-0.55	7.71	10.05	9.05	8.16	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cellebrite DI Cash Flow

What is Cellebrite DI's free cash flow?

Cellebrite DI generated free cash flow of $160.32M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $173.54M minus $13.22M of capital expenditures. That was up 29.7% from $123.61M a year earlier. Free cash flow equaled 33.7% of revenue.

How much does Cellebrite DI spend on capital expenditures?

Cellebrite DI spent $13.22M on capital expenditures in fiscal 2025, compared with $8.57M a year earlier. That equals 7.6% of operating cash flow.

Does Cellebrite DI pay dividends or buy back shares?

Cellebrite DI's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition